| Code | Description | Claims | Beneficiaries | Total Paid |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,311 |
3,294 |
$150K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
2,828 |
2,737 |
$75K |
| 92250 |
|
2,217 |
2,199 |
$41K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
622 |
621 |
$39K |
| 92134 |
|
1,851 |
1,794 |
$28K |
| 92083 |
|
996 |
990 |
$27K |
| 92133 |
|
768 |
762 |
$12K |
| 92226 |
|
801 |
549 |
$9K |
| 92020 |
|
936 |
929 |
$8K |
| 92202 |
|
1,609 |
1,597 |
$8K |
| 92136 |
|
292 |
254 |
$7K |
| 92235 |
|
138 |
136 |
$4K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
27 |
25 |
$837.77 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22 |
21 |
$416.13 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12 |
12 |
$373.63 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
13 |
$96.03 |
| 99072 |
|
331 |
291 |
$0.03 |
| 4177F |
|
432 |
419 |
$0.00 |
| 3072F |
|
146 |
136 |
$0.00 |
| 1036F |
|
2,003 |
1,929 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
1,795 |
1,730 |
$0.00 |
| 0517F |
|
443 |
433 |
$0.00 |
| 2026F |
|
419 |
404 |
$0.00 |
| 4040F |
|
1,869 |
1,800 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,984 |
1,911 |
$0.00 |
| 2022F |
|
419 |
404 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
606 |
587 |
$0.00 |
| 2024F |
|
419 |
404 |
$0.00 |
| 2027F |
|
12 |
12 |
$0.00 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
61 |
55 |
$0.00 |
| 2021F |
|
13 |
13 |
$0.00 |